{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Primary Sclerosing Cholangitis and other Risk Factors for Posttransplant Lymphoproliferative Disease after Liver Transplantation in Adults


Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify risk factors for posttransplant lymphoproliferative disease (PTLD).
  2. Explain strategies to prevent PTLD.
Price: $30.00


  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: LVT0624
Published: June 2024
Expires: 5/31/2026
Required Passing Score: 3/4 (75%)
Authors: Bastian N. Ruijter, Maarten E. Tushuizen, Danny van der Helm, Mitchel Hew, Marjolein Reeven, Ann C.T.M. Vossen, Herold J. Metselaar, Ian P. J. Alwayn, Jeroen Dubbeld, Wojciech G. Polak, and Bart van Hoek
Categories: Hepatology
Specialties: Hepatology